Kampanjeplan MaxCyte, Inc.
Avansert tidsplan
Enkel graf
Om selskapet MaxCyte, Inc.
MaxCyte, Inc. работает как компания, специализирующаяся на клеточной терапии и биологических науках в США и за рубежом. Его системы трансфекции включают MaxCyte STX, масштабируемую систему трансфекции, которая использует технологию проточной электропорации для конструирования клеток для ряда приложений; MaxCyte VLX, инструмент для инженерии клеток большого объема; и MaxCyte GT, невирусная технология клеточной инженерии, разработанная для клинического использования. flere detaljerIPO date | 2021-07-30 |
---|---|
ISIN | US57777K1060 |
Industry | Health Care Equipment & Supplies |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.maxcyte.com |
Цена ао | 4.56 |
Prisendring per dag: | -2.1% (4.76) |
---|---|
Prisendring per uke: | -5.67% (4.94) |
Prisendring per måned: | +13.38% (4.11) |
Prisendring over 3 måneder: | +30.53% (3.57) |
Prisendring over seks måneder: | -0.2141% (4.67) |
Prisendring per år: | -7.36% (5.03) |
Prisendring over 3 år: | -27.86% (6.46) |
Prisendring over 5 år: | 0% (4.66) |
Prisendring over 10 år: | 0% (4.66) |
Prisendring siden begynnelsen av året: | +7.37% (4.34) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Institusjoner | Volum | Dele, % |
---|---|---|
Blackrock Inc. | 7 | 6.93 |
Cadian Capital Management, LP | 7 | 6.28 |
Millennium Management LLC | 6 | 5.91 |
Vanguard Group Inc | 5 | 5.12 |
Vitruvian Partners, LLP | 5 | 4.83 |
Morgan Stanley | 4 | 3.37 |
FMR, LLC | 3 | 3.3 |
Massachusetts Financial Services Co. | 3 | 2.42 |
Mudita Advisors LLP | 2 | 2.18 |
Geode Capital Management, LLC | 2 | 2.04 |
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Mr. Douglas Arthur Doerfler | Founder | 1.2M | 1956 (69 år) |
Mr. Ronald Evan Holtz CPA, Ph.D. | Executive Vice President of Administration | 649.38k | 1958 (67 år) |
Mr. Thomas Michael Ross | Executive Vice President of Global Sales | N/A | 1961 (64 år) |
Mr. Douglas J. Swirsky CFA, CPA | Chief Financial Officer | N/A | 1969 (56 år) |
Mr. Jack Horgan | Vice President of Corporate Development | N/A | |
Mr. Maher Masoud | President, CEO & Executive Director | 612.07k | 1975 (50 år) |
Mr. Jay Gelfman | Senior Vice President of Operations | N/A | |
Mr. David Sandoval | Senior Vice President, General Counsel & Corporate Secretary | N/A | 1978 (47 år) |
Ms. Jill Mayer | Senior Vice President of Human Resources | N/A | |
Dr. J. Stark Thompson Ph.D. | Consultant | 1942 (83 år) |
Adresse: United States, Gaithersburg, MD , 22 Firstfield Road - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.maxcyte.com
Nettsted: https://www.maxcyte.com